NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

心房纖維顫動 (AF) 治療市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年

Atrial Fibrillation Market, By Procedure (Pharmacological, Non-Pharmacological ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 959459
出版日期 內容資訊 英文 140 Pages
商品交期: 2-3個工作天內
價格
心房纖維顫動 (AF) 治療市場 - 市場規模,佔有率,預測,機會分析:2020年∼2027年 Atrial Fibrillation Market, By Procedure (Pharmacological, Non-Pharmacological ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年09月01日內容資訊: 英文 140 Pages
簡介

心房纖維顫動 (AF) ,是由於心臟電氣系統的障礙引起的心律異常區別的心臟的心律不整的一種。在預測期間中,預計產品核可的增加,心房纖維顫動的高盛行率,促進市場成長。

本報告提供全球心房纖維顫動 (AF) 治療市場相關調查分析,市場概要,市場規模與預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 調查目的與前提條件

第2章 市場範圍

第3章 市場動態、規定、趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 主要的焦點
  • 產品銷售
  • PEST分析
  • 技術的進步
  • 法規方案
  • M&A

第4章 全球心房纖維顫動 (AF) 治療市場:各治療

  • 簡介
  • 藥理學性
  • 非藥理學性

第5章 全球心房纖維顫動 (AF) 治療市場:各地區

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第6章 競爭情形

  • 企業簡介
    • AtriCure, Inc.
    • Biosense Webster, Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Corporation
    • CardioFocus, Inc.
    • Endoscopic Technologies, Inc.
    • Sanofi Aventis
    • Johnson and Johnson Ltd.
    • Abbott Laboratories

第7章 Section

目錄

Title:
Atrial Fibrillation Market, By Procedure (Pharmacological (Anti-arrhythmic, Anti-coagulant), Non-Pharmacological (Catheter Ablation Procedures, Maze surgery, Electric Cardioversion)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & AFrica) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Atrial Fibrillation is also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. It is linked with an elevated risk of heart failure, stroke, and dementia. Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. High prevalence of atrial fibrillation along with increasing product approvals during the forecasted period is expected to assist the growth of the market. Furthermore, major players in the global atrial fibrillation market are focused on R&D to expand their product portfolio which is also expected to drive the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Atrial Fibrillation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Atrial Fibrillation market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Inc., Johnson and Johnson Ltd., and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Atrial Fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Atrial Fibrillation market

Detailed Segmentation:

  • Global Atrial Fibrillation Market, By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
  • Global Atrial Fibrillation Market, By Region:
  • North America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion s
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • AtriCure, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Biosense Webster, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis, Inc.
  • Johnson and Johnson Ltd.
  • Abbott Laboratories
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Atrial Fibrillation Market, By Procedure, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion

5. Global Atrial Fibrillation Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • AtriCure, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biosense Webster, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CardioFocus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Endoscopic Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi Aventis
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact